![]() | Up a level |
Number of items: 1.
Romito, Ilaria, Porru, Manuela, Braghini, Maria Rita, Pompili, Luca, Panera, Nadia, Crudele, Annalisa, Gnani, Daniela, De Stefanis, Cristiano, Scarsella, Marco, Pomella, Silvia et al (show 12 more authors)
(2021)
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 40 (1).
364-.